TopFunds

Medpace

NASDAQ: MEDP

Stock price

537.73 USD

(+Infinity%) NaN day

medical researchMedical - Diagnostics & ResearchInvestable Universe

Financial Performance

Share

5Y price score: 268

Help

The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.

A score of 100 indicates that the stock did as well as the S&P 500 Index.

A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.

10Y return: 1,835%

DATE RANGE:

US$ Per
Share

    Time scale:

    By default your notes are visible only to you.

    306.7

    52-week range

    628.9

    537.73

    Your model inputs

    Required return / cost of capital
    %
    FCFF terminal growth rate
    %

    Your fair value & Margin of safety

    To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.

    Forecast:

    Valuation

    Free Cash Flow Yield

    Help
    FCF Yield TTM = Trailing Twelve Months free cash flow per share / current market price per shareLearn more

    4.7 %

    Dividend Yield TTM

    -

    Market cap $

    $ 15,357

    Price / Earnings TTM

    Help
    P/E TTM = current market price per share / Trailing Twelve Months diluted earnings per shareLearn more

    33.8

    Price / Book TTM

    25.6

    PEG TTM

    Help
    Price/Earnings-to-Growth ratio = P/E TTM divided by most recent annual diluted earnings per share growth rateLearn more

    1.6

    Earnings growth and return

    LTM

    5YR

    10YR

    Total return (price & dividends)

    68.5 %

    193.9 %

    1,835 %

    Free cash flow per share growth

    29.2 %

    283 %

    1,052.6 %

    Earnings per share growth

    21 %

    297.9 %

    5,557.1 %

    Founded: 1,992

    Employees: 5,900

    Business Summary:Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.

    Fair Value Reference Estimate

    Latest Earnings Call Takeaways

    Annual Reports, Presentations And IR Contacts

    Go to the website
    Annual report links (10K)
    2025202420232022202120202019201820172016

    Medpace — Financial Overview, Stock Price, Market Cap

    Medpace is a company. Founded in 1992. As of July 20, 2026, the company's market capitalization is $15357401566 with a current stock price of $537.73.